ATR AptarGroup, Inc.
Healthcare$116.58+0.00%OpenMarket Cap: $7.44B
As of 2026-05-26
Valuation
P/E (TTM)
21.56
PEG
4.46
P/B
2.83
P/S
1.92
EV/EBITDA
10.73
DCF Value
$171.51
FCF Yield
4.4%
Div Yield
1.6%
Margins & Returns
Gross Margin
29.0%
Operating Margin
13.0%
Net Margin
10.0%
ROE
14.3%
ROA
7.6%
ROIC
9.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $982.9M | 28.1% | $108.6M | $72.7M | $— | $0.48 |
| Q4 null | $962.7M | 27.2% | $110.7M | $74.3M | $— | $0.48 |
| FY null | $3.78B | 29.6% | $512.3M | $392.8M | $— | $1.83 |
| Q3 null | $961.1M | 29.9% | $139.1M | $127.9M | $— | $0.45 |
| Q2 null | $966.0M | 30.8% | $146.0M | $111.7M | $— | $0.45 |
| Q1 null | $887.3M | 30.5% | $115.5M | $78.8M | $— | $0.45 |
| Q4 null | $848.1M | 38.8% | $120.1M | $100.9M | $— | $0.45 |
| FY null | $3.58B | 37.8% | $496.5M | $374.5M | $— | $1.72 |
| Q3 null | $909.3M | 38.6% | $138.3M | $100.0M | $— | $0.45 |
| Q2 null | $910.1M | 37.6% | $126.0M | $90.5M | $— | $0.41 |
| Q1 null | $915.4M | 36.3% | $112.1M | $83.1M | $— | $0.41 |
| Q4 2023 | $838.5M | 37.2% | $84.2M | $62.4M | $0.93 | $0.41 |